Skip to main content
    S

    Serina Therapeutics Inc (SER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.42
    +0.03 (+2.16%)

    Market Cap: $36.93M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Serina Therapeutics Inc (SER) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Serina Therapeutics (SER) is expected to report earnings on May 10, 2027. In the quarter ended Sep 30, 2026, Serina Therapeutics reported EPS of -$0.31, above the -$0.34 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    50%(4/8)
    Avg Surprise
    -31.00%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.30
    Range-$0.32 - -$0.28
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    SER has an expected report date of May 10, 2027.

    Earnings History

    Of the 8 quarters below that had an estimate, SER beat 4 and missed 4. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 184.79% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.31-$0.34-$0.37 - -$0.31+8.82%BeatN/A22 up, 0 downNov 12, 2026$125000
    Jun 30, 2026-$0.55-$0.35-$0.35 - -$0.35-57.14%MissN/A11 up, 0 downAug 13, 2026N/A
    Mar 31, 2026-$0.53-$0.44-$0.44 - -$0.44-20.45%MissN/A11 up, 0 downMay 14, 2026N/A
    Dec 31, 2025-$0.31-$0.50-$0.50 - -$0.50+38.00%BeatN/A10 up, 1 downMar 25, 2026N/A
    Sep 30, 2025-$0.51-$0.53-$0.59 - -$0.47+3.77%Beat-488.7%20 up, 1 downNov 13, 2025N/A
    Jun 30, 2025-$0.66-$0.42-$0.43 - -$0.36-57.14%Miss-228.8%21 up, 0 downAug 11, 2025$130000
    Mar 31, 2025-$0.49-$0.62-$0.62 - -$0.62+20.97%BeatN/A10 up, 0 downMay 8, 2025N/A
    Dec 31, 2024-$0.36$0.42$0.42 - $0.42-184.79%MissN/A10 up, 0 downMar 24, 2025N/A
    Sep 30, 2024$0.13N/AN/AN/AN/AN/AN/AN/ANov 12, 2024$14000
    Jun 30, 2024$0.51N/AN/AN/AN/AN/AN/AN/AAug 9, 2024$51000
    Mar 31, 2024-$3.38N/AN/AN/AN/AN/AN/AN/AMay 14, 2024$5000
    Dec 31, 2023-$3.20N/AN/AN/AN/AN/AN/AN/AMar 22, 2024$3.09M
    Sep 30, 2023-$5.01N/AN/AN/AN/AN/AN/AN/ANov 14, 2023$29000
    Jun 30, 2023-$2.47N/AN/AN/AN/AN/AN/AN/ASep 28, 2023$7000
    Mar 31, 2023-$3.04N/AN/AN/AN/AN/AN/AN/AMar 31, 2023$30000
    Dec 31, 2022-$0.07N/AN/AN/AN/AN/AN/AN/AMar 29, 2023$8000
    Sep 30, 2022-$0.06N/AN/AN/AN/AN/AN/AN/ADec 29, 2022$9000
    Jun 30, 2022-$0.07N/AN/AN/AN/AN/AN/AN/ASep 28, 2022$12000
    Mar 31, 2022-$0.07N/AN/AN/AN/AN/AN/AN/AJun 28, 2022$5000
    Dec 31, 2021-$0.06N/AN/AN/AN/AN/AN/AN/AMar 29, 2022$27000
    Sep 30, 2021-$0.05N/AN/AN/AN/AN/AN/AN/ADec 29, 2021$24000
    Jun 30, 2021-$0.07N/AN/AN/AN/AN/AN/AN/ASep 28, 2021$37000
    Mar 31, 2021-$0.05N/AN/AN/AN/AN/AN/AN/AJun 28, 2021$56000
    Dec 31, 2020-$0.06N/AN/AN/AN/AN/AN/AN/AMar 30, 2021$292000
    Sep 30, 2020-$0.07N/AN/AN/AN/AN/AN/AN/ANov 16, 2020$69000
    Jun 30, 2020-$0.07N/AN/AN/AN/AN/AN/AN/AAug 14, 2020N/A
    Mar 31, 2020-$0.08N/AN/AN/AN/AN/AN/AN/AJun 29, 2020N/A
    Dec 31, 2019-$0.07N/AN/AN/AN/AN/AN/AN/AMar 30, 2020$549000
    Sep 30, 2019-$0.09N/AN/AN/AN/AN/AN/AN/ANov 14, 2019$411000
    Jun 30, 2019-$0.08N/AN/AN/AN/AN/AN/AN/AAug 14, 2019$380000
    Mar 31, 2019-$0.09N/AN/AN/AN/AN/AN/AN/AJun 29, 2019$388000
    Dec 31, 2018-$3.13N/AN/AN/AN/AN/AN/AN/AMar 30, 2019$313000
    Sep 30, 2018-$0.05N/AN/AN/AN/AN/AN/AN/AOct 22, 2018$380000
    Jun 30, 2018-$0.01N/AN/AN/AN/AN/AN/AN/AJul 19, 2018$464000
    Last 34 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.97, after -$3.09 the year before. It was -$3.19 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.97N/A
    Dec 31, 2024-$3.09N/A
    Dec 31, 2023-$13.72N/A
    Dec 31, 2022-$0.27N/A
    Dec 31, 2021-$0.23N/A
    Dec 31, 2020-$0.28N/A
    Dec 31, 2019-$0.33N/A
    Dec 31, 2018-$3.19N/A

    Frequently Asked Questions About SER

    When is Serina Therapeutics's next earnings date?

    Serina Therapeutics's next earnings report is expected for May 10, 2027.

    Did SER beat earnings estimates last quarter?

    Yes. Serina Therapeutics reported EPS of -$0.31 for the quarter ended Sep 30, 2026, above the -$0.34 estimate, a 8.82% surprise.

    What EPS do analysts expect from SER next quarter?

    The consensus EPS estimate for Serina Therapeutics for the quarter ending Dec 31, 2026 is -$0.30 from 3 analysts, with estimates from -$0.32 to -$0.28.

    How often does SER beat earnings estimates?

    Serina Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -31.00%.